期刊文献+

奥洛他定滴眼液联合普拉洛芬滴眼液治疗过敏性结膜炎的临床观察 被引量:11

Clinical Observation on Olopatadine Eye Drops Combined With Pranoprofen Eye Drops in the Treatment of Allergic Conjunctivitis
在线阅读 下载PDF
导出
摘要 目的研究探讨对过敏性结膜炎患者应用奥洛他定滴眼液联合普拉洛芬滴眼液治疗的临床效果。方法选取2016年5月—2017年5月我院收治的130例过敏性结膜炎患者,并按挂号先后平均分成对照组与观察组,对照组患者使用奥洛他定滴眼液治疗,观察组患者应用奥洛他定滴眼液联合普拉洛芬滴眼液治疗,对比两组患者治疗效果。结果观察组治疗总有效率为96.92%,对照组治疗总有效率为83.07%,观察组明显优于对照组,差异有统计学意义(P<0.05)。结论奥洛他定滴眼液联合普拉洛芬滴眼液治疗过敏性结膜炎的效果显著,且安全性高。 Objective To study the clinical effect of olopatadine eye drops combined with pranoprofen eye drops in patients with allergic conjunctivitis.Methods130patients with allergic conjunctivitis admitted to our hospital from May2016to May2017were divided into control group and observation group according to the registered number,the patients in the control group were treated with olopatadine eye drops,patients in the observation group were treated with olopatadine eye drops and pranoprofen eye drops,and the treatment effect was compared between the two groups.Results The total effective rate was96.92%in the observation group and83.07%in the control group.The observation group was significantly better than the control group(P<0.05).Conclusion Olopatadine eye drops combined with pranoprofen eye drops for the treatment of allergic conjunctivitis has significant effect,and high safety.
作者 缪恺 陈艳榕 MIAO Kai;CHEN Yanrong(Department of Ophthalmology, Fujian Medical University Affiliated Ningde City Hospital, Ningde Fujian 352100, China)
出处 《中国卫生标准管理》 2018年第6期63-65,共3页 China Health Standard Management
关键词 过敏性结膜炎 奥洛他定滴眼液 普拉洛芬滴眼液 allergic conjunctivitis olopatadine eye drops pranoprofen eye drops
  • 相关文献

参考文献10

二级参考文献59

  • 1刘祖国,肖启国.过敏性结膜炎的诊治[J].中华眼科杂志,2004,40(7):500-502. 被引量:65
  • 2刘祖国,姚勇,孙秉基,孙兴怀,谢汉平,王红,万修华,崔敏,陈龙山,张梅.过敏性结膜炎的临床特点[J].中国实用眼科杂志,2004,22(9):694-697. 被引量:96
  • 3Berdy GJ, Hedqvist B.Ocular allergic disorders and dry eye disease: asslociations, diagnostic dilemmas, and management[J].Acta Ophthalmol Scand suppl,2000,78 ( s230 ): 32-37.
  • 4Berdy GJ, Stoppe] JO, Epstein AB.Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthahnic solution and loteprednnl etabnnate 0.2% ophthahnic suspension in the conjunctival allergen challenge model[J].Clin Ther,2002,24 ( 6 ) : 918-929.
  • 5Mah FS, OB'rien T, Kim T, et al.Evaluation of the effects of olopatadine ophthalmic solution 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye[J].CurrMed Res Opin, 2008,24 ( 2 ) : 441-447.
  • 6Abelson MB, Gomes PJ, Pasquine T, et al.Efficacy of olopatadine ophthalmic solutinn 0.2% in reducing signs and symptoms of allergic conjmwtivitis[J]. Allergy Asthma Proc, 2007,28 ( 4 ) : 427-433.
  • 7Swamy BN, Chilov M, McClellan K, et al.Topical non-steroidal anti- inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data[J].Ophthalmic Epidemiol, 2007,14 ( 5 ) : 3 l 1-319.
  • 8Abelson MB,Gomes PJ,Pasquine T,et al.Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis[J] .Allergy Asthma Proc,2007,28(4):427-433.
  • 9Swamy BN,Chilov M,Mclellan K,et al.Topical non-steroidal anti inflammatorydrugs in allergic conjunctivitis:meta-analysis of randomizedtrial data[J] .Ophthalmic Epidemiol,2007,14(5):311-319.
  • 10Mah FS,O'Brien T,Kim T,et al.Evaluation of the effects of olopatadine ophthalmic solution 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye[J] .Curr Med Res Opin,2008,24(2):441-447.

共引文献99

同被引文献85

引证文献11

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部